We assessed whether there were serum GP73 changes that were associated with liver disease progression from nonexistent or mild to severe hepatitis, and, furthermore, whether serum GP73 changes were associated with chronic hepatitis B complications. This evidence concerns the gene GOLM1 and chronic hepatitis B virus infection.